David W. Braun

3.3k total citations · 1 hit paper
21 papers, 2.5k citations indexed

About

David W. Braun is a scholar working on Oncology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, David W. Braun has authored 21 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 8 papers in Pathology and Forensic Medicine and 6 papers in Cancer Research. Recurrent topics in David W. Braun's work include Breast Lesions and Carcinomas (6 papers), Breast Cancer Treatment Studies (6 papers) and Cancer and Skin Lesions (2 papers). David W. Braun is often cited by papers focused on Breast Lesions and Carcinomas (6 papers), Breast Cancer Treatment Studies (6 papers) and Cancer and Skin Lesions (2 papers). David W. Braun collaborates with scholars based in United States. David W. Braun's co-authors include Paul Peter Rosen, Richard J. Gralla, Charles W. Young, David W. Kinne, Philip Lieberman, Patricia E. Saigo, Elizabeth Weathers, Loretta M. Itri, Thomas J. Braun and David P. Kelsen and has published in prestigious journals such as New England Journal of Medicine, Annals of Internal Medicine and JNCI Journal of the National Cancer Institute.

In The Last Decade

David W. Braun

21 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antiemetic Efficacy of High-Dose Metoclopramide: Randomized Trials with Placebo and Prochlorperazine in Patients with Chemotherapy-Induced Nausea and Vomiting

1981 555 citations Richard J. Gralla, Loretta M. Itri et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by David W. Braun

Since Specialization

Citations

This map shows the geographic impact of David W. Braun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David W. Braun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David W. Braun more than expected).

Fields of papers citing papers by David W. Braun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David W. Braun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David W. Braun. The network helps show where David W. Braun may publish in the future.

Co-authorship network of co-authors of David W. Braun

This figure shows the co-authorship network connecting the top 25 collaborators of David W. Braun. A scholar is included among the top collaborators of David W. Braun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David W. Braun. David W. Braun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Corynebacterium parvum toxicity in patients with limited and advanced malignancy 1984 ·European Journal of Cancer and Clinical Oncology ·Yashar Hirshaut, Carl Pinsky, Harry Wanebo, David W. Braun	2
2	Cisplatin, vindesine and bleomycin (CVB) combination chemotherapy of advanced non-small cell lung cancer 1983 ·Cancer ·Loretta M. Itri, Richard J. Gralla, David P. Kelsen, Robert Chapman, Ephraim S. Casper, David W. Braun, Jane Howard, Robert Golbey, Robert T. Heelan	16
3	Prognostic factors in advanced colorectal carcinoma 1983 ·The American Journal of Medicine ·Nancy E. Kemeny, David W. Braun	109
4	Occult axillary lymph node metastases from breast cancers with intramammary lymphatic tumor emboli 1982 ·The American Journal of Surgical Pathology ·Paul Peter Rosen, Edward J. Beattie, Patricia E. Saigo, David W. Kinne, David W. Braun	33
5	DNCB reactivity and prognosis in 419 patients with malignant melanoma 1981 ·Cancer ·Elber S. Camacho, Carl Pinsky, David W. Braun, Robert B. Golbey, Joseph G. Fortner, Harold J. Wanebo, Herbert F. Oettgen	8
6	Methotrexate: An active drug in bladder cancer 1981 ·Cancer ·Ronald B. Natale, Alan Yagoda, Robin C. Watson, Willet F. Whitmore, Martin S. Blumenreich, David W. Braun	71
7	Antiemetic Efficacy of High-Dose Metoclopramide: Randomized Trials with Placebo and Prochlorperazine in Patients with Chemotherapy-Induced Nausea and Vomiting breakdown → 1981 ·New England Journal of Medicine ·Richard J. Gralla, Loretta M. Itri, (unknown), (unknown), David P. Kelsen, David W. Braun, (unknown), Thomas J. Braun, Charles W. Young	555
8	Cisplatin and Vindesine Combination Chemotherapy for Advanced Carcinoma of the Lung: A Randomized Trial Investigating Two Dosage Schedules 1981 ·Annals of Internal Medicine ·Richard J. Gralla, Ephraim S. Casper, David P. Kelsen, David W. Braun, M Dukeman, Nael Martini, Charles W. Young, Robert B. Golbey	283
9	Prognosis in Stage II “T1N1M0”Breast Cancer 1981 ·Annals of Surgery ·Paul Peter Rosen, Patricia E. Saigo, David W. Braun, Elizabeth Weathers, David W. Kinne	59
10	VAB-3 combination chemotherapy of metastatic testicular cancer 1981 ·Cancer ·Thomas F. Reynolds, Davor Vugrin, Esteban Cvitkovic, Edgar Cheng, David W. Braun, (unknown), M Dukeman, Willet F. Whitmore, Robert B. Golbey	57
11	Surgical adjuvant therapy of malignant melanoma withCorynebacterium parvum 1981 ·Cancer ·(unknown), Carl Pinsky, Yashar Hirshaut, Harold J. Wanebo, John A. Hansen, David W. Braun, Joseph G. Fortner, Herbert F. Oettgen	20
12	Angiosarcoma and other vascular tumors of the breast 1981 ·The American Journal of Surgical Pathology ·(unknown), Paul Peter Rosen, Philip Lieberman, Richard J. Kaufman, Saul Kay, David W. Braun, David W. Kinne	191
13	Natural Cytotoxicity of Peripheral Blood Lymphocytes and Regional Lymph Node Cells in Breast Cancer in Women<xref ref-type="fn" rid="fn2">2</xref><xref ref-type="fn" rid="fn3">3</xref> 1981 ·JNCI Journal of the National Cancer Institute ·S. Cunningham‐Rundles, D Filippa, David W. Braun, Paola Antonelli, (unknown)	78
14	Lobular carcinomain situ of the breast: Preliminary results of treatment by ipsilateral mastectomy and contralateral breast biopsy 1981 ·Cancer ·Paul Peter Rosen, David W. Braun, (unknown), Jerome A. Urban, David W. Kinne	58
15	Predictors of Recurrence in Stage I (T1N0M0) Breast Carcinoma 1981 ·Annals of Surgery ·Paul Peter Rosen, Patricia E. Saigo, David W. Braun, Elizabeth Weathers, (unknown)	152
16	Burn Injury 1980 ·Annals of Surgery ·P. William Curreri, Arnold Luterman, David W. Braun, G T Shires	119
17	Immunologic reactivity and prognosis in breast cancer 1980 ·Cancer ·Susan E. Krown, Carl Pinsky, Harold J. Wanebo, David W. Braun, Peter Wong, Herbert F. Oettgen	22
18	The clinical significance of pre-invasive breast carcinoma 1980 ·Cancer ·Paul Peter Rosen, David W. Braun, (unknown)	248
19	In vitro mitogenic effect of Zn2+ on peripheral blood lymphocytes in patients with cancer 1980 ·International Journal of Immunopharmacology ·John Garofalo, Susanna Cunningham–Rundles, David W. Braun, Robert A. Good	7
20	Lobular carcinoma in situ of the breast Detailed analysis of 99 patients with average follow-up of 24 years 1978 ·The American Journal of Surgical Pathology ·Paul Peter Rosen, Philip Lieberman, David W. Braun, Cynthia Kosloff, Frank E. Adair	271

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact